INVO Bioscience Inc
NASDAQ:INVO
INVO Bioscience Inc
NASDAQ:INVO
Price:
0.78 USD
1.3%
Market Closed
Updated:
Jun 9, 2024
INVO Bioscience Inc
Net Issuance of Common Stock
|
INVO Bioscience Inc
Net Issuance of Common Stock Peer Comparison
Comparables:
BSX
SYK
ABT
ISRG
SWAV
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
INVO Bioscience Inc
NASDAQ:INVO
|
Net Issuance of Common Stock
$3.5m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
159%
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Issuance of Common Stock
$199m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Net Issuance of Common Stock
-$674m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
12%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Issuance of Common Stock
$310.2m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Shockwave Medical Inc
NASDAQ:SWAV
|
Net Issuance of Common Stock
$9.2m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
See Also
What is INVO Bioscience Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
3.5m
USD
3.5m
USD
Based on the financial report for Mar 31, 2024, INVO Bioscience Inc's Net Issuance of Common Stock amounts to 3.5m USD.
What is INVO Bioscience Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
159%
159%
Over the last year, the Net Issuance of Common Stock growth was 31%. The average annual Net Issuance of Common Stock growth rates for INVO Bioscience Inc have been -33% over the past three years , 159% over the past five years .
You don't have any saved screeners yet
